Phase i trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma

M. R. Litzow, P. P. Peethambaram, S. L. Safgren, G. L. Keeney, S. M. Ansell, A. Dispenzieri, M. A. Elliott, D. A. Gastineau, M. A. Gertz, D. J. Inwards, M. Q. Lacy, I. N.M. Micallef, L. F. Porrata, W. L. Lingle, L. C. Hartmann, M. H. Frost, B. A. Barrette, H. J. Long, V. J. Suman, J. M. ReidM. M. Ames, S. H. Kaufmann

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences